Loading
Latest filing published 18 Apr 2025 for GYRE THERAPEUTICS, INC., €91k. Read the official filing
No signal scores available.
Our data holds just one disclosure by Thomas Wilson Eastling, dated 18 April 2025, reporting an option exercise worth €91k in Gyre Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration